Unresolved disorder model. using A ATOM 4643 N AGLN 602 55.262 -7.886 27.499 0.50 18.02 N Unresolved disorder model. using A ATOM 4644 N BGLN 602 55.268 -7.895 27.506 0.50 18.56 N Unresolved disorder model. using A ATOM 4645 CA AGLN 602 54.736 -6.577 27.106 0.50 17.40 C Unresolved disorder model. using A ATOM 4646 CA BGLN 602 54.720 -6.600 27.122 0.50 18.41 C Unresolved disorder model. using A ATOM 4647 C AGLN 602 55.811 -5.504 27.324 0.50 17.89 C Unresolved disorder model. using A ATOM 4648 C BGLN 602 55.732 -5.470 27.389 0.50 18.63 C Unresolved disorder model. using A ATOM 4649 O AGLN 602 55.942 -4.565 26.537 0.50 17.71 O Unresolved disorder model. using A ATOM 4650 O BGLN 602 55.739 -4.452 26.696 0.50 18.90 O Unresolved disorder model. using A ATOM 4651 CB AGLN 602 53.485 -6.241 27.936 0.50 16.54 C Unresolved disorder model. using A ATOM 4652 CB BGLN 602 53.396 -6.401 27.865 0.50 18.51 C Unresolved disorder model. using A ATOM 4653 CG AGLN 602 52.658 -5.056 27.419 0.50 15.88 C Unresolved disorder model. using A ATOM 4654 CG BGLN 602 52.487 -7.641 27.718 0.50 19.51 C Unresolved disorder model. using A ATOM 4655 CD AGLN 602 51.383 -4.806 28.227 0.50 15.20 C Unresolved disorder model. using A ATOM 4656 CD BGLN 602 51.170 -7.546 28.475 0.50 19.06 C Unresolved disorder model. using A ATOM 4657 OE1AGLN 602 50.855 -5.709 28.867 0.50 19.08 O Unresolved disorder model. using A ATOM 4658 OE1BGLN 602 51.135 -7.148 29.636 0.50 19.67 O Unresolved disorder model. using A ATOM 4659 NE2AGLN 602 50.881 -3.587 28.181 0.50 10.94 N Unresolved disorder model. using A ATOM 4660 NE2BGLN 602 50.080 -7.933 27.820 0.50 18.07 N 1